January 11, 2018 / 1:34 PM / in 8 months

BRIEF-Immunovia Signs LoI With DD2 Center

Jan 11 (Reuters) - IMMUNOVIA AB (PUBL):

* ‍SIGNED A LETTER OF INTENT FOR COLLABORATION WITH DANISH CENTER FOR STRATEGIC RESEARCH INTO TYPE 2 DIABETES​

* ‍INTENTION IS DD2 CENTER WILL BE PART OF GROUNDBREAKING PANDIA-1 PROSPECTIVE STUDY INTO NEW ONSET TYPE 2 DIABETICS​

* IMMUNOVIA ACCELERATES PANCREAS CANCER STUDY OF NEW ONSET DIABETICS BY ADDING DENMARK’S DIABETES CENTER FOR STRATEGIC RESEARCH-DD2 Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below